Service Description

To prepare a trial for a new formulation of a therapeutic haemophilia medicine, based on a freeze-dried coagulation factor.

What Went Well

The appropriate patient group was assembled; the trial was executed on time; reports and data analysis were appropriate and of good quality.

What Could Be Improved

There was nothing that could be improved, the service was good.

Lessons Learned from the Experience

The CRO provided helpful advice, especially in designing the study so it lent itself to robust statistical analysis.